Blume-Jensen Peter

Acrivon Therapeutics, Inc. Common Stock · President and CEO

Blume-Jensen Peter is listed in public filings as director, officer: President and CEO. This Blume-Jensen Peter insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Acrivon Therapeutics, Inc. Common Stock (ACRV). Investors use Blume-Jensen Peter's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Acrivon Therapeutics, Inc. Common StockACRV	$4.0M2.2M shares	Grant / ExerciseMay 21, 2026	$24.6K13.7k shares	$1.79	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Acrivon Therapeutics, Inc. Common StockACRV	--386.3k shares	Grant / ExerciseMay 18, 2026	Disclosure amount unavailable72.7k shares	--	--
Acrivon Therapeutics, Inc. Common StockACRV	--2.3M shares	Grant / ExerciseMay 18, 2026	Disclosure amount unavailable180.1k shares	--	--
Acrivon Therapeutics, Inc. Common StockACRV	$4.0M2.1M shares	Grant / ExerciseMay 14, 2026	$2.4K1.3k shares	$1.92	--
Acrivon Therapeutics, Inc. Common StockACRV	$602k313.6k shares	Grant / ExerciseMay 14, 2026	$941490 shares	$1.92	--
Acrivon Therapeutics, Inc. Common StockACRV	$630k417.2k shares	Grant / ExerciseMar 1, 2026	$630.0K417.2k shares	$1.51	--
Acrivon Therapeutics, Inc. Common StockACRV	$280k185.5k shares	Grant / ExerciseMar 1, 2026	$280.1K185.5k shares	$1.51	--
Acrivon Therapeutics, Inc. Common StockACRV	$3.2M2.1M shares	Grant / ExerciseFeb 21, 2026	$21.8K14.3k shares	$1.53	--
Acrivon Therapeutics, Inc. Common StockACRV	$3.4M2.1M shares	Grant / ExerciseFeb 14, 2026	$2.1K1.3k shares	$1.63	--
Acrivon Therapeutics, Inc. Common StockACRV	$512k314.1k shares	Grant / ExerciseFeb 14, 2026	$944579 shares	$1.63	--
Acrivon Therapeutics, Inc. Common StockACRV	$3.5M2.1M shares	BuyJan 14, 2026	$82.1K49k shares	$1.68	--
Acrivon Therapeutics, Inc. Common StockACRV	$4.7M2M shares	Grant / ExerciseNov 21, 2025	$45.8K19.9k shares	$2.30	--
Acrivon Therapeutics, Inc. Common StockACRV	$705k314.7k shares	Grant / ExerciseNov 14, 2025	$1.1K490 shares	$2.24	--
Acrivon Therapeutics, Inc. Common StockACRV	$4.6M2.1M shares	Grant / ExerciseNov 14, 2025	$133.9K59.8k shares	$2.24	--
Acrivon Therapeutics, Inc. Common StockACRV	$2.8M2.1M shares	Grant / ExerciseAug 21, 2025	$26.3K19.9k shares	$1.32	--
Acrivon Therapeutics, Inc. Common StockACRV	$438k315.2k shares	Grant / ExerciseAug 14, 2025	$681490 shares	$1.39	--
Acrivon Therapeutics, Inc. Common StockACRV	$3.0M2.1M shares	Grant / ExerciseAug 14, 2025	$83.1K59.8k shares	$1.39	--
Acrivon Therapeutics, Inc. Common StockACRV	$2.5M2.2M shares	Grant / ExerciseMay 21, 2025	$22.9K19.9k shares	$1.15	--
Acrivon Therapeutics, Inc. Common StockACRV	$360k315.7k shares	Grant / ExerciseMay 14, 2025	$560491 shares	$1.14	--
Acrivon Therapeutics, Inc. Common StockACRV	$2.5M2.2M shares	Grant / ExerciseMay 14, 2025	$68.1K59.8k shares	$1.14	--
Acrivon Therapeutics, Inc. Common StockACRV	$2.1M390.4k shares	Grant / ExerciseMar 1, 2025	$2.1M390.4k shares	$5.31	--
Acrivon Therapeutics, Inc. Common StockACRV	$746k140.5k shares	Grant / ExerciseMar 1, 2025	$746.3K140.5k shares	$5.31	--
Acrivon Therapeutics, Inc. Common StockACRV	$13M2.3M shares	Grant / ExerciseFeb 21, 2025	$110.3K19.9k shares	$5.54	--
Acrivon Therapeutics, Inc. Common StockACRV	$12M2.3M shares	Grant / ExerciseFeb 14, 2025	$201.4K37.2k shares	$5.42	--
Acrivon Therapeutics, Inc. Common StockACRV	$1.7M316.2k shares	Grant / ExerciseFeb 14, 2025	$3.1K579 shares	$5.42	--
Acrivon Therapeutics, Inc. Common StockACRV	$15M2.3M shares	Grant / ExerciseNov 21, 2024	$128.2K19.9k shares	$6.44	--
Acrivon Therapeutics, Inc. Common StockACRV	$19M2.4M shares	Grant / ExerciseNov 14, 2024	$473.3K59.8k shares	$7.92	--
Acrivon Therapeutics, Inc. Common StockACRV	$2.5M316.8k shares	Grant / ExerciseNov 14, 2024	$3.9K490 shares	$7.92	--
Acrivon Therapeutics, Inc. Common StockACRV	$22M2.4M shares	Grant / ExerciseAug 21, 2024	$731.7K79.6k shares	$9.19	--
Acrivon Therapeutics, Inc. Common StockACRV	$18M2.5M shares	Grant / ExerciseAug 14, 2024	$419.6K59.8k shares	$7.02	--